Company: SMNR
Filing Date: 2025-03-27
Form Type: DEF 14A
Source: 0001013762-25-003461
Chunk: 21

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-03-27
Form: DEF 14A
Chunk 21
---
 forward -looking. Forward -lookingstatements in this proxy statement may include, for example, statements about: •Our ability to effect the extension; •our ability to select an appropriate target business or businesses; •our ability to complete our initial business combination, including our recently announced proposed business combination with Semnur; •our expectations around the performance of the prospective target business or businesses; •our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; •our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination; •our potential ability to obtain additional financing to complete our initial business combination; •our pool of prospective target businesses; •our ability to consummate an initial business combination due to the uncertainty resulting from the ongoing military action with the country of Ukraine commenced by the Russian Federation and Belarus in February 2022, adverse changes in general economic industry and competitive conditions, or adverse changes in government regulation or prevailing market interest rates; •the ability of our officers and directors to generate a number of potential business combination opportunities; •our public securities’ potential liquidity and trading; •the lack of a market for our securities; •the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; •the trust account not being subject to claims of third parties; or •our financial performance following our initial public offering. The forward -lookingstatements contained in this proxy statement are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward -lookingstatements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward -lookingstatements. These risks and uncertainties include, but are not limited to, those factors described under the heading “Risk Factors” in this proxy statement and in our Annual Report on Form 10 -Kfor the year ended December 31, 2023 and in our other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward -lookingstatements. We undertake no obligation to update or revise any forward -lookingstatements, whether as a result of new information, future events